Source: BIOPORTFOLIO

Silvergate: FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Silvergate Pharmaceuticals Inc. focused on the development and commercialization of innovative and safe medicines for children today announced that the United States Food and Drug Administration approved Epaned for the treatment of symptomatic heart failur...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Neal I. Muni's photo - President & CEO of Silvergate Pharmaceuticals

President & CEO

Neal I. Muni

CEO Approval Rating

90/100

Read more